1 魏虎来.硒酸酯多糖和亚硒酸钠抗白血病效应的实验研究[J]. 兰州大学学报(自然科学版), 1996;32:122-5 2 Wei HL, Su HX, Yao XJ, Ma LF.Biological feature of human T-activated killer cells[J]. Chin JCancer Res, 1999;11:111-4 3 李尹雄.核酸的分离与纯化[A]. 见:卢圣栋, 主编.现代分子生物学实验技术[M]. 第 2版.北京:中国协和医科大学出版社, 1999:107-8 4 Boffa LC, Scarfi S, Maariani MR, Damonte G, Allfrey VC, Benatti U, et al.Dihydrotestoterone as selective cellular nucle-ar location vector for antigene peptide nucleic acid in prostatic carcinoma cells[J]. Cancer Res, 2000;60:2258-62 5 Aggarwal S, Gupta S.Increased apoptosis of T cell subsets in aging humans:altered expression of Fas (CD95), Fas ligand, Bcl -2, and Bax[J]. J Immunol, 1998;160:1627-37 6 Djebaili M, De Bock F, Baille V.Implication of P53 and caspase-3 in kainic acid but not in N-methyl-D-aspartic acid-induced apoptosis in organotypic hippocampal mouse cultures [J]. Neurosci Lett, 2002;327:1-4 7 Wei HL, Su HX, Bai DC, Zhao HS, Ge JG, Wang B, et al. Arsenic trioxide inhibits P-glycoprotein expression of multidrug-resistant human leukemia cells that overexpress mdr-1 gene and induces apoptosis[J]. Chin Med J, 2003;116:1644-8 8 吴兴, 陈峥嵘, 陈中伟.硒酸酯多糖诱导人骨肉瘤细胞凋亡作用的体外实验[J]. 肿瘤防治杂志, 2004;11:927-30 9 Caffrey PB, Frenkel GD.The development of drug resistance by tumor cells invitro isaccompanied by the development of sensi-tivity to selenite[J]. Cancer Lett, 1994;81:59-65 10 穆玉兰, 温泽清, 汤春生.微量元素与肿瘤耐药性关系的研究进展[J]. 中国癌症杂志, 2002;12:184-6 11 Liu SL, Shia DY, Liu GZ, Chen HL, Liu SJ, Hu YD.Roles of Se andNO in apoptosis of hepatoma cells[J]. Life Science, 2000;68:603-10 12 Mahadevan D, List AF.Targeting the multidrug resistance-1 transporter in AML:molecular regulation and therapeutic strate-gies[J]. Blood, 2004;104:1940-51 13 Johnstone RW, Cretney E, Smyth MJ.P-glycoprotein protects leukemia cells against caspase-dependent, but not caspase-in-dependent, cell death[J]. Blood, 1999;93:1075-85 14 Pallis M, Turzanski J, Higashi Y, Russell N.P-glycoprotein in acute myeloid leukaemia:therapeutic implicationsof itsasso-ciation with both a multidrug-resistant and an apoptosis-resistant phenotype[J]. Leuk Lymphoma, 2002;43:1221-8 |